Artificial Intelligence for Assessment of Stargardt Macular Atrophy

Information

  • Research Project
  • 10077550
  • ApplicationId
    10077550
  • Core Project Number
    R21EY029839
  • Full Project Number
    5R21EY029839-02
  • Serial Number
    029839
  • FOA Number
    PA-19-053
  • Sub Project Id
  • Project Start Date
    1/1/2020 - 5 years ago
  • Project End Date
    12/31/2021 - 3 years ago
  • Program Officer Name
    SHEN, GRACE L
  • Budget Start Date
    1/1/2021 - 4 years ago
  • Budget End Date
    12/31/2021 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    12/14/2020 - 4 years ago
Organizations

Artificial Intelligence for Assessment of Stargardt Macular Atrophy

Project Abstract Stargardt disease is the most frequent form of inherited juvenile macular degeneration. Fundus autofluorescence (FAF) is a widely available imaging technique which may aid in the diagnosis of Stargardt disease and is commonly used to monitor its progression. FAF imaging provides an in vivo assay of the retinal layers, but is only an indirect measure. Spectral-domain optical coherence tomography (SD-OCT), in contrast, provides three-dimensional visualization of the retinal microstructure, thereby allowing it to be assessed directly and individually in eyes with Stargardt disease. At a retinal disease endpoints meeting with the Food and Drug Administration (FDA) in November of 2016, a reliable measure of the anatomic status of the integrity of the ellipsoid zone (EZ) in the retina, was proposed to be a potential suitable regulatory endpoint for therapeutic intervention clinical trials. Manual segmentation/identification of the EZ band, particularly in 3-D OCT images, has proven to be extremely tedious, time-consuming, and expensive. Automated objective segmentation techniques, such as an approach using a deep learning - artificial intelligence (AI) construct, would be of significant value. Moreover, Stargardt disease may cause severe visual loss in children and young adults. Early prediction of Stargardt disease progression may facilitate new therapeutic trials. Thus, this proposal develops an AI-based approach for automated Stargardt atrophy segmentation and the prediction of atrophy progression in FAF and OCT images. More specifically, we first register the longitudinal FAF and OCT enface images respectively, and register the cross-sectional FAF to OCT image. We then develop a 2-D approach for Stargardt atrophy segmentation from FAF images using an AI approach and a 3-D approach for EZ band segmentation from OCT images using a 3-D graph-based approach. Finally, an AI-based approach is developed to predict subsequent development of new Stargardt atrophy or progression of existing atrophy from the OCT EZ band thickness and intensity features of the current patient visit.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    R21
  • Administering IC
    EY
  • Application Type
    5
  • Direct Cost Amount
    112500
  • Indirect Cost Amount
    64125
  • Total Cost
    176625
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    867
  • Ed Inst. Type
  • Funding ICs
    NEI:176625\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    DOHENY EYE INSTITUTE
  • Organization Department
  • Organization DUNS
    020738787
  • Organization City
    LOS ANGELES
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    900331035
  • Organization District
    UNITED STATES